Village Farms International, Inc. current report, 08 September 2020

Business Context and Reporting Period

Company: Village Farms International, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 8, 2020
Reporting Period: Events occurring on September 8, 2020, with anticipated closing dates in Q4 2020.

Key Financial Metrics and Transaction Details

This filing reports on two primary financial events: an acquisition and a capital raise. No historical revenue, profit, or cash flow metrics are provided in this specific document.

  • Acquisition Cost: C$79.9 million (subject to adjustments) to purchase 36,958,500 shares of Pure Sunfarms Corp. (41.3% stake).
  • Capital Raise (Offering): Sale of 9,396,226 Units at $5.30 per Unit.
  • Expected Net Proceeds: Approximately $46.8 million (after placement agent fees, before offering expenses).
  • Use of Proceeds: Up to $40 million allocated to finance the Pure Sunfarms acquisition; remainder for general working capital.
  • Warrant Terms: 0.50 warrant per Unit, exercisable starting March 10, 2021, at $5.80 per share, expiring in five years.
  • Transaction Fees: 6% cash fee to placement agent (A.G.P./Alliance Global Partners); up to $100,000 expense reimbursement.

Material Changes and Agreements

The filing details the entry into material definitive agreements on September 8, 2020:

  • Acquisition of Pure Sunfarms: Village Farms entered a Purchase Agreement with Emerald Health Therapeutics, Inc. to acquire the remaining interest in Pure Sunfarms not already held by Village Farms. This transaction will result in Village Farms owning 100% of Pure Sunfarms upon closing.
  • Registered Direct Offering: Village Farms entered Securities Purchase Agreements with institutional investors to raise capital specifically to fund the acquisition.
  • Indemnification: Mutual indemnification between Village Farms and Emerald with a C$500,000 deductible and a cap of 100% of the purchase price.
  • Termination Fees: Emerald agreed to pay a C$3 million termination fee under specified events and up to C$1 million in expense reimbursement fees.

Guidance, Outlook, Risks, and Contingencies

Outlook and Timing:

  • Acquisition Closing: Anticipated to occur in the fourth quarter of 2020, specifically on the fifth business day following satisfaction of conditions.
  • Offering Closing: Expected on or about September 10, 2020.
  • Shareholder Approval: Emerald must convene a shareholder meeting by October 30, 2020, to approve the acquisition.
Risks and Contingencies:
  • Closing Conditions: The acquisition is subject to customary conditions, including regulatory approvals, lender consents (Pure Sunfarms and Village Farms), and TSX Venture Exchange consent.
  • Termination Rights: Either party may terminate if the closing does not occur by November 30, 2020, or if shareholder approval is not obtained.
  • Leak-Out Agreement: Investors are restricted from selling more than 25% of the daily trading volume of Village Farms shares if the price is below $5.75 per share until November 10, 2020.
  • Non-Solicitation: A three-year non-solicitation agreement regarding employees will be entered into on the Closing Date.
Management Commentary:

The filing does not contain explicit forward-looking earnings guidance or management commentary on operational performance, focusing strictly on the transaction mechanics.

Key Facts for Investor Verification

  • Verify the final closing date of the Pure Sunfarms acquisition and whether all regulatory and lender consents were obtained by November 30, 2020.
  • Confirm the actual net proceeds received from the Registered Direct Offering and the final allocation of funds toward the acquisition versus working capital.
  • Monitor the exercise of warrants issued in the offering, which begin March 10, 2021, and their potential dilutive impact.
  • Check for any subsequent filings regarding the termination of the Purchase Agreement or the payment of the C$3 million termination fee.
  • Review the full text of the Purchase Agreement (Exhibit 10.1) for specific representations and warranties that may affect the valuation of Pure Sunfarms.